The study of Lamotrigine and Bupropion for Meniere's Disease

The company Dent Neuroscience Research Center is commencing recruitment for the clinical trial of the Lamotrigine and Bupropion for Meniere's Disease.

The conditions are Meniere Disease, Ménière's Vertigo, Vertigo, Intermittent, Vertigo, Aural.

The trial officially began on the December 16, 2020 and is planned to complete on December 2024.

This is a double-blind, placebo-controlled clinical trial to assess whether treatment with lamotrigine and bupropion is more effective than placebo to reduce definitive Meniere's vertigo attacks (DMVA) and dizziness in patients with Meniere's disease. Thirty four participants will be randomized to treatment or placebo groups. Each participant will take part in the trial for 34 weeks, or approximately 9 months.

Cures Within Reach, Dent Family Foundation are the collaborators in this clinical trial.

The link to the complete study profile: https://ichgcp.net/clinical-trials-registry/NCT05420350 or https://clinicaltrials.gov/ct2/show/NCT05420350.

Clinical Research News

Upcoming Clinical Trials